CROI 2022

CROI 2022
February 12-16, 2022
Virtual Conference

Conference on Retroviruses and Opportunistic Infections.

Explore more information for Gilead HIV / AIDS therapies
Material Type
Filter by Keyword(s)

Filter results with keywords such as:

  • Name of author(s)
  • Disease state
  • Indication
  • Trial phase
  • Trial name
  • Trial date

Note: Multiple keywords can be applied at the same time.

    Results (14)

    Evaluation of HIV-1 Recency Assays Among Prospectively Observed HIV-1 Seroconversions

    • Author(s): Cox, S
    • descovy-for-prep
    • HIV / AIDS

    Immunological and Glycomic Correlates of Time to HIV Rebound in Viremic Controllers

    • Author(s): Cai, Y
    • vestalimod (gs-9620)
    • HIV / AIDS

    Immunogenicity and Prophylactic Efficacy of Arenavirus-Based SIV Vaccine in Macaques

    • Author(s): Boopathy, A
    • other
    • HIV / AIDS

    Viral and Biomarker Outcomes of an Engineered bNAb in ART-Suppressed Participants

    • Author(s): Cai, Y
    • elipovimab (gs-9722)
    • HIV / AIDS

    Remdesivir Treatment for COVID-19 in Hospitalized Children: CARAVAN Interim Results

    • Author(s): Ahmed, A
    • veklury
    • COVID-19

    Remdesivir in an Outpatient Setting Improves Biomarkers for Progression of COVID-19

    • Author(s): Pan, D
    • veklury
    • COVID-19

    Pharmacokinetics of Lenacapavir in Participants With Severe Renal Impairment

    • Author(s): Weber, E
    • lenacapavir
    • HIV / AIDS

    Safety of Remdesivir vs Placebo in Nonhospitalized Patients With COVID-19

    • Author(s): Webb, B
    • veklury
    • COVID-19

    Long Acting Lenacapavir Protects Against Intravenous Challenge with Simian-Tropic HIV

    • Author(s): Swanstrom, A
    • lenacapavir
    • HIV / AIDS

    Long-Acting Lenacapavir in People With Multidrug-Resistant HIV-1: Week 52 Results

    • Author(s): Ogbuagu, O
    • lenacapavir
    • HIV / AIDS

    Evaluation of Potential Drug-Drug Interactions Between Islatravir and Lenacapavir

    • Author(s): Zhang, H
    • lenacapavir
    • HIV / AIDS

    B/F/TAF Five-Year Outcomes in Treatment-Naïve Adults

    • Author(s): Wohl, D
    • biktarvy
    • HIV / AIDS

    Absence of Cross-Resistance to Lenacapavir in HIV Entry Inhibitor-Resistant Isolates

    • Author(s): Margot, N
    • lenacapavir
    • HIV / AIDS

    Lenacapavir as part of a Combination Regimen in Treatment-Naïve People with HIV: Week 54 Results

    • Author(s): Gupta, S
    • lenacapavir
    • HIV / AIDS